• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

维生素 E TPGS 对 P-糖蛋白的抑制机制:对构象灵活性、细胞内 ATP 水平的影响,以及进入时间和位置的作用。

Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.

机构信息

Biopharmaceutics and Pharmaceutical Technology, Saarland University, 66123 Saarbrucken, Germany.

出版信息

Mol Pharm. 2010 Jun 7;7(3):642-51. doi: 10.1021/mp900191s.

DOI:10.1021/mp900191s
PMID:20205474
Abstract

Previous work conducted in our laboratories established the notion that TPGS 1000 (d-alpha-tocopheryl polyethylene glycol 1000 succinate), a nonionic surfactant, modulates P-glycoprotein (P-gp) efflux transport via P-gp ATPase inhibition. The current in vitro research using Caco-2 cells was conducted to further explore the P-gp ATPase inhibition mechanism. Using a monoclonal CD243 P-gp antibody shift assay (UIC2), we probed P-gp conformational changes induced via TPGS 1000. In the presence of TPGS 1000, UIC2 binding was slightly decreased. TPGS 1000 does not appear to be a P-gp substrate, nor does it function as a competitive inhibitor in P-gp substrate efflux transport. The reduction in UIC2 binding with TPGS 1000 was markedly weaker than with orthovanadate, data ruling out trapping P-gp in a transition state by direct interaction with one or both of the P-gp ATP nucleotide binding domains. An intracellular ATP depletion mechanism could be ruled out in the UIC2 assay, and by monitoring intracellular ATP levels in the presence of TPGS 1000. Indicating slow distribution of TPGS 1000 into the membrane, and in agreement with an intramembranal or intracellular side of action, Caco-2 cell monolayer experiments preincubated with TPGS 1000 produce stronger substrate inhibitory activity than those conducted by direct substrate and surfactant coapplication.

摘要

先前在我们实验室进行的工作确立了这样一种观点,即 TPGS1000(d-α-生育酚聚乙二醇 1000 琥珀酸酯),一种非离子表面活性剂,通过抑制 P-糖蛋白(P-gp)ATP 酶来调节 P-gp 外排转运。本研究使用 Caco-2 细胞进行了进一步的体外研究,以探索 P-gp ATP 酶抑制机制。通过使用单克隆 CD243 P-gp 抗体移位测定法(UIC2),我们研究了 TPGS1000 诱导的 P-gp 构象变化。在 TPGS1000 的存在下,UIC2 结合略有减少。TPGS1000 似乎不是 P-gp 的底物,也不是 P-gp 底物外排转运的竞争性抑制剂。与钒酸盐相比,TPGS1000 减少 UIC2 结合的作用明显较弱,这排除了 P-gp 通过与一个或两个 P-gp ATP 核苷酸结合域的直接相互作用而被捕获在过渡态的可能性。在 UIC2 测定中可以排除细胞内 ATP 耗竭机制,并且可以通过监测 TPGS1000 存在时细胞内 ATP 水平来排除这种机制。这表明 TPGS1000 缓慢分布到膜中,并且与跨膜内或细胞内作用一致,用 TPGS1000 预孵育的 Caco-2 细胞单层实验产生比直接应用底物和表面活性剂更强的底物抑制活性。

相似文献

1
Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access.维生素 E TPGS 对 P-糖蛋白的抑制机制:对构象灵活性、细胞内 ATP 水平的影响,以及进入时间和位置的作用。
Mol Pharm. 2010 Jun 7;7(3):642-51. doi: 10.1021/mp900191s.
2
Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity.维生素E TPGS抑制P-糖蛋白介导的外排的机制:对ATP酶活性和膜流动性的影响。
Mol Pharm. 2007 May-Jun;4(3):465-74. doi: 10.1021/mp060121r. Epub 2007 Mar 17.
3
Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS.使用新型非离子表面活性剂抑制外排:基于维生素E TPGS的合理设计。
Int J Pharm. 2009 Mar 31;370(1-2):93-102. doi: 10.1016/j.ijpharm.2008.11.021. Epub 2008 Nov 30.
4
An in vitro examination of the impact of polyethylene glycol 400, Pluronic P85, and vitamin E d-alpha-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine.聚乙二醇400、普朗尼克P85和维生素E琥珀酸聚乙二醇1000维生素E对大鼠离体肠中P-糖蛋白外排和肠细胞代谢影响的体外研究。
AAPS PharmSci. 2002;4(4):E40. doi: 10.1208/ps040440.
5
P-glycoprotein and surfactants: effect on intestinal talinolol absorption.P-糖蛋白与表面活性剂:对肠道他林洛尔吸收的影响
Clin Pharmacol Ther. 2005 Jan;77(1):24-32. doi: 10.1016/j.clpt.2004.09.001.
6
Inhibition mechanism of P-glycoprotein mediated efflux by mPEG-PLA and influence of PLA chain length on P-glycoprotein inhibition activity.甲氧基聚乙二醇-聚乳酸介导的P-糖蛋白外排抑制机制及聚乳酸链长度对P-糖蛋白抑制活性的影响
Mol Pharm. 2014 Jan 6;11(1):71-80. doi: 10.1021/mp4004223. Epub 2013 Nov 22.
7
Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.维生素E TPGS聚乙二醇链长度对Caco-2细胞单层顶端外排转运体的影响。
J Control Release. 2006 Mar 10;111(1-2):35-40. doi: 10.1016/j.jconrel.2005.11.005. Epub 2006 Jan 10.
8
Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS).琥珀酸聚乙二醇1000维生素E(TPGS)对P-糖蛋白的抑制作用。
Pharm Res. 1999 Oct;16(10):1550-6. doi: 10.1023/a:1015000503629.
9
Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo.维生素E-TPGS增强口服紫杉醇的吸收:对体外、原位和体内溶解度及渗透性的影响
Eur J Pharm Sci. 2005 Jul-Aug;25(4-5):445-53. doi: 10.1016/j.ejps.2005.04.003.
10
The applications of Vitamin E TPGS in drug delivery.维生素 E TPGS 在药物传递中的应用。
Eur J Pharm Sci. 2013 May 13;49(2):175-86. doi: 10.1016/j.ejps.2013.02.006. Epub 2013 Feb 26.

引用本文的文献

1
Oral Metronomic Delivery of Atorvastatin and Docetaxel via Transporter-Targeted Nanoemulsions Enhances Antitumor Efficacy and Immune Modulation in Colon Cancer.通过靶向转运体的纳米乳剂口服节律性给药阿托伐他汀和多西他赛可增强结肠癌的抗肿瘤疗效和免疫调节作用。
Pharmaceutics. 2025 Jul 2;17(7):872. doi: 10.3390/pharmaceutics17070872.
2
Drug Nanocrystals in Oral Absorption: Factors That Influence Pharmacokinetics.口服吸收中的药物纳米晶体:影响药代动力学的因素
Pharmaceutics. 2024 Aug 29;16(9):1141. doi: 10.3390/pharmaceutics16091141.
3
Polycaprolactone-Vitamin E TPGS Micellar Formulation for Oral Delivery of Paclitaxel.
用于口服递送紫杉醇的聚己内酯 - 维生素E TPGS胶束制剂
Polymers (Basel). 2024 Aug 5;16(15):2232. doi: 10.3390/polym16152232.
4
Polycaprolactone - Vitamin E TPGS micelles for delivery of paclitaxel: In vitro and in vivo evaluation.用于紫杉醇递送的聚己内酯 - 维生素E TPGS胶束:体外和体内评价
Int J Pharm X. 2024 May 3;7:100253. doi: 10.1016/j.ijpx.2024.100253. eCollection 2024 Jun.
5
Encapsulation of Olive Leaf Polyphenol-Rich Extract in Polymeric Micelles to Improve Its Intestinal Permeability.将富含橄榄叶多酚的提取物包裹于聚合物胶束中以提高其肠道通透性。
Nanomaterials (Basel). 2023 Dec 15;13(24):3147. doi: 10.3390/nano13243147.
6
Smart fluorescent polysaccharides: Recent developments and applications.智能荧光多糖:最新进展及应用。
Carbohydr Polym. 2024 Jan 15;324:121471. doi: 10.1016/j.carbpol.2023.121471. Epub 2023 Oct 8.
7
Quaternization of high molecular weight chitosan for increasing intestinal drug absorption using Caco-2 cells as an in vitro intestinal model.季铵化高分子量壳聚糖以提高肠道药物吸收:以 Caco-2 细胞作为体外肠道模型。
Sci Rep. 2023 May 16;13(1):7904. doi: 10.1038/s41598-023-34888-0.
8
Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression.使用 XAV939 纳米颗粒靶向 β-连环蛋白可促进免疫原性细胞死亡并抑制结膜黑色素瘤的进展。
Int J Pharm. 2023 Jun 10;640:123043. doi: 10.1016/j.ijpharm.2023.123043. Epub 2023 May 11.
9
Vitamin E TPGS-Based Nanomedicine, Nanotheranostics, and Targeted Drug Delivery: Past, Present, and Future.基于维生素E TPGS的纳米药物、纳米诊疗学与靶向给药:过去、现在与未来
Pharmaceutics. 2023 Feb 21;15(3):722. doi: 10.3390/pharmaceutics15030722.
10
Enhancement of the anticancer effect of atorvastatin-loaded nanoemulsions by improving oral absorption via multivalent intestinal transporter-targeting lipids.多价肠黏膜转运体靶向脂质提高载阿托伐他汀纳米乳口服吸收增强其抗癌作用。
Drug Deliv. 2022 Dec;29(1):3397-3413. doi: 10.1080/10717544.2022.2149896.